Malika Ammam received her MS degree from the University of Pierre et Marie CURIE in July 2002 and her PhD from the University of Paris Sud XI, France in September 2005. From 2006 to 2007, she worked as a research fellow at the University of Kansas in collaboration with Pinnacle Technology Inc. (USA). From 2007 to 2010, she was a research associate at KU Leuven, Belgium. From 2010 to 2012, she worked at the University of Ontario Institute of Technology in collaboration with Alcohol Countermeasure Systems Corporation, Canada. She held a prestigious Rosalind Franklin fellowship and resigned in 2015. Now, she is a freelancer.
A study reviewed literature dealing with surgical management of small bowel, large bowel and perianal Crohn’s disease (CD) to identify those ... Read more
Researchers have found that a wheat protein called amylase-trypsin inhibitors (ATIs) could be linked to the development of inflammatory bowel disease ... Read more
A $36 million grant will be invested over the next five years to study gastrointestinal conditions, including inflammatory bowel disease (IBD). ... Read more
The location of intestinal stem cells and their proliferation inhibitors were recently identified in a study “The Colonic Crypt Protects Stem ... Read more
Origin Sciences Ltd has initiated a performance study of its OriCol device in measuring calprotectin, a validated biomarker of inflammation, in the stool and rectal mucus of ... Read more
Cytori Therapeutics, a company specializing in the development of cell therapies for the treatment of various medical conditions, recently announced the start ... Read more
In a recently published paper in the Inflammatory Bowel Diseases journal, entitled “Prevalence of Inflammatory Bowel Disease Among Patients with Autism ... Read more
